Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Arens, R.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(81 - 100 of 116)

Pages

Vaccine-Induced Tumor Necrosis Factor-Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis
The activation of the adaptive immune system: Cross-talk between antigen-presenting cells, T cells and B cells
T Cell Factor 1 Represses CD8(+) Effector T Cell Formation and Function
Enhanced Cross-Presentation and Improved CD8(+) T Cell Responses after Mannosylation of Synthetic Long Peptides in Mice
New advances in CMV and immunosenescence
Viral inoculum dose impacts memory T-cell inflation
An Unexpected Intriguing Effect of Toll-Like Receptor Regulator RP105 (CD180) on Atherosclerosis Formation With Alterations on B-Cell Activation
Nodular Inflammatory Foci Are Sites of T Cell Priming and Control of Murine Cytomegalovirus Infection in the Neonatal Lung
Local immunomodulation for cancer therapy Providing treatment where needed
T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development
Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8(+) T-Cell-Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
RP105 (cd180) as a TLR-4 regulator ameliorates atherosclerosis via its role on B-cells
Lysine Acetyltransferase PCAF Is a Key Regulator of Arteriogenesis
The distinct role of T cell costimulation in antiviral immunity
CD27-CD70 Costimulation Controls T Cell Immunity during Acute and Persistent Cytomegalovirus Infection
Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironment
Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer
Priming of CD8(+) T Cells against Cytomegalovirus-Encoded Antigens Is Dominated by Cross-Presentation
Predicting the efficacy of cancer vaccines by evaluating T-cell responses

Pages